Global Muscle relaxant drugs Oxygen Concentrators Market Size

Muscle Relaxant Drugs Market Size By Product Type (Skeletal muscle relaxants, Neuromuscular blockers, Centrally acting muscle relaxants, Direct acting muscle relaxants, Others), By Application Type (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) Other Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: BMRC 1059 | Number of pages: 200 | Publish Date: Jan 2021
    Status: Published | Category: Healthcare | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Muscle Relaxant Drugs Market Size By Product Type (Skeletal muscle relaxants, Neuromuscular blockers, Centrally acting muscle relaxants, Direct acting muscle relaxants, Others), By Application Type (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) Other Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Global Muscle Relaxant Drugs Market is valued at USD 3.34 Billion in 2017 and expected to reach USD 5.77 Billion by 2027 with a CAGR of 5.6% over the forecast period.

Global Muscle Relaxant Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Increasing in back problems and health issues associated with older generation are key driving factors for the growth of Global Muscle Relaxant Drugs Market.

Scope of Global Muscle Relaxant Drugs Market Report:

The Muscle Relaxant Medications are used to relive the muscle pains often known as muscle spasms. This condition is related to or directly affects the nervous system. Other associated conditions are motor neuron disease, cerebral palsy and multiple sclerosis. Moreover, muscle spasms can result into head or back long term difficulties. It is recommended to obtain these drugs on doctor’s prescription as they have potential to reduce the spasm and stress of the muscles. Since, these drugs make the central nervous system to slow down, they are considered to be suitable for younger adult generation. The patients with other medical problems like liver, kidney or heart diseases should avoid taking these relaxant drugs which may result into other side effects. Muscle relaxant drugs are considered to be addictive hence it should be taken with precautions and for short period of time. Also it is highly advised to keep them away from children and other adults.    

Increasing prevalence of lower back pain with surge in number of surgeries in geriatric population as well as rising healthcare expenditures of relaxant drugs are expected to boost the growth of muscle relaxant drugs market over forecast period.

The regions covered in this Global Muscle Relaxant Drugs Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Medical Tourism is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia, Africa, etc.

Key Players for Global Muscle Relaxant Drugs Market Report:

Some major key players for Global Muscle Relaxant Drugs Market are Pfizer Inc., F.Hoffmann-La Roche Ltd, Galderma S.A., Intas Pharmaceuticals Ltd., Johnson & Johnson, Merck & Co. and others.

Global Muscle Relaxant Drugs Market Dynamics:

Rising prevalence of musculoskeletal problems and growing awareness amongst the consumers regarding their treatment and management are expected to be the dynamic factors behind the growth of global market of muscle relaxant drugs. According to the World Health Organization (WHO), the non-specific burden of lower back pain has been increased substantially around the globe which is estimated at 60–70% in industrialized countries whereas one-year prevalence increasing rate 15–45%, adult incidence 5% per year and mostly occurrence of LBP has seen in above 35 age group people. However, severe side effects related to muscle relaxant drugs such as habituation and respiratory arrest will restrict the growth of global muscle relaxant drugs market. The recent technologically improved muscle relaxants are structurally distinct drugs prescribed for reducing muscle spasms, pain, and hyperreflexia. Centrally acting skeletal muscle relaxants are manufactured by various pharmaceutical companies with variable price. The present study, aimed to analyze the cost variation of various brands of centrally acting skeletal muscle relaxants, so as to help the physician to choose the cost effective treatment to drive the market growth.

News: Long term Use of Muscle Relaxant has skyrocketed since 2005

June 25, 2020; According to Perelman School of Medicine, researchers reported that the usage of relaxant drugs tripled in 2016 from 2005. They also observed that around 70% patients were prescribed relaxants drugs having opioid combination, consider causing dangerous interactions. They also reported that these drugs were prescribed to elderly patients which should always be avoided as per the national guidelines. These results were published in JAMA Network Open.

Rising prevalence of chronic back problems coupled with surge in number of surgeries are key driving factors for the growth of Global Muscle Relaxant Drugs Market

The major factor driving the growth of global Muscle Relaxant Drugs market is rising prevalence of chronic back problems followed by the surge in geriatric population prone to muscle pain or spasm. According to World Health Organization (WHO), back pain patients have been estimated to increase from 60% to 70% in major countries. The U.S. Food and Drug Administration are against the usage of muscle relaxants and opioids together as this combination can cause some issues. But doctors still prescribe these medications as there are no alternatives available. This factor can be considered as driving agent to the market. The long term usage of these drugs can result to some potential side effects like drowsiness, headache, fatigue and others. These drugs are restricted for the patients having liver, kidney and heart disease as well as stringent regulatory policies for approval are likely to hamper the growth of muscle relaxant drugs market. on the other hand, surge in R&D activities for the development of novel drugs along with FDA approvals and strategic collaborations in the market is expected to create opportunities.

North America is Dominating the Global Muscle Relaxant Drugs Market

North America is expected to dominate the global Muscle Relaxant Drugs market over the forecast period attributed to the rising number of surgical procedures couple with high disposable income. Moreover, high prevalence rate of chronic back supported by the presence of huge geriatric population in this region. For example; World Health Organization reported that America has more than 50% aging population followed by Asia Pacific. Asia Pacific is expected to develop at a significant rate over the forecast period owing to the development in healthcare infrastructure. Furthermore, better accessibility to healthcare facilities followed by the launch of generic formulations and geographical expansion by key market players. All the above mentioned factors is expected to augment the growth of muscle relaxant drugs market. 

  Report Coverage

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2027
Market Size in 2020: USD 3.34 Billion
Base year considered 2020
Forecast Period CAGR %: 5.60 %
Market Size Expected in 2027: USD 5.77 Billion
Tables, Charts & Figures: 175
Pages 200
Key Players/Companies Pfizer Inc., F.Hoffmann-La Roche Ltd, Galderma S.A., Intas Pharmaceuticals Ltd., Johnson & Johnson, Merck & Co. and others
Segments Covered By Product Type, By Application Type
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Global Muscle Relaxant Drugs Market Report:

  • Global Muscle Relaxant Drugs Market report covers in-depth historical and forecast analysis.
  • Global Muscle Relaxant Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global Muscle Relaxant Drugs Market report helps to identify opportunities in marketplace.
  • Global Muscle Relaxant Drugs Market report covers extensive analysis of emerging trends and competitive landscape.

Global Muscle Relaxant Drugs Market Segmentation:

Global Muscle Relaxant Drugs Market report is segmented on the basis of type, application and region & country level. Based upon drug type, global Muscle Relaxant Drugs market is classified into skeletal muscle relaxants, neuromuscular blockers, centrally acting muscle relaxants, direct acting muscle relaxants and others. Based upon the application, global muscle relaxant drugs market is classified into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy.

By Product Type:

  • Skeletal muscle relaxants
  • Neuromuscular blockers
  • Centrally acting muscle relaxants
  • Direct acting muscle relaxants
  • Others

By Application Type:

  • Retail Pharmacy
  • Hospital Pharmacy

Muscle Relaxant Drugs Market By Regional & Country Level:

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

Latin America

  • Brazil
  • Mexico

Middle East and Africa

    • GCC
    • Africa
    • Rest of Middle East and Africa


Frequently Asked Questions (FAQ) :
Global Muscle Relaxant Drugs Market is valued at USD 3.34 Billion in 2017 and expected to reach USD 5.77 Billion by 2027 with a CAGR of 5.6% over the forecast period.
Pfizer Inc., F.Hoffmann-La Roche Ltd, Galderma S.A., Intas Pharmaceuticals Ltd., Johnson & Johnson, Merck & Co. and others
Rising prevalence of chronic back problems coupled with surge in number of surgeries are key driving factors for the growth of Global Muscle Relaxant Drugs Market



Interested in this report?

Muscle relaxant drugs Size 2021 | Demand and Analysis 2027 and Analysis 2019-2025

report cover

Muscle Relaxant Drugs Market Size By Product Type (Skeletal muscle relaxants, Neuromuscular blockers, Centrally acting muscle relaxants, Direct acting muscle relaxants, Others), By Application Type (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) Other Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.

    Pricing


+44-1173181773
vishal@brandessenceresearch.com


Looking for Regional Reports?